Latest News & Features
Americas
The UK pharma giant has opened a new front in its global litigation strategy involving Moderna, Pfizer, and BioNTech. 5 September 2025
Americas
The Finnish wearable tech brand is fighting hard to fend off younger rivals, with the battleground getting bloody. Sarah Speight reports. 5 September 2025
Europe
The company’s EPO victory over a rare disease biomarker patent highlights how precise claims and attention to objections can make or break biotech cases, reports Marisa Woutersen. 4 September 2025
Americas
The deal brings to a close a clash over DNA sequencing technology for cancer detection, with both sides agreeing to dismiss their claims. 4 September 2025
Americas
The company’s decision to sue US customs may result in a “roadmap” to sidestep ITC orders—and patent litigators are watching, finds Marisa Woutersen. 3 September 2025
Europe
Carpmaels & Ransford appoints two litigation partners as the UK firm expands its presence in Germany in response to UPC demand. 3 September 2025
Europe
A High Court decision clarifies how cross-undertakings work in patent disputes, rejecting claims for exceptional remedies beyond compensation. 2 September 2025
Biotechnology
Erik Viik of Papula-Nevinpat looks at the dynamics that international applicants need to be aware of to secure and manage their patent rights across the region. 2 September 2025
Americas
Non-practising entities are controversial, but political winds in the US are shifting and inventors, investors, and operating companies of all stripes should take note, writes Manny Caixeiro of Venable. 1 September 2025
Europe
A rare “innovator v innovator” case puts Pfizer in the firing line over its COVID-19 drug, highlighting the Unified Patent Court as an attractive forum for ‘David vs Goliath’ scenarios, say experts. 29 August 2025